UBS Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $139K | Buy |
|
|||||
|
2024
Q3 | $3.97K | Sell |
|
|||||
|
2024
Q2 | $22.3K | Sell |
|
|||||
|
2024
Q1 | $1.12M | Buy |
|
|||||
|
2023
Q4 | $903K | Buy |
|
|||||
|
2023
Q3 | $452K | Buy |
|
|||||
|
2023
Q2 | $391K | Sell |
|
|||||
|
2023
Q1 | $585K | Buy |
|
|||||
|
2022
Q4 | $302K | Sell |
|
|||||
|
2022
Q3 | $641K | Buy |
|
|||||
|
2022
Q2 | $465K | Buy |
|
|||||
|
2022
Q1 | $317K | Sell |
|
|||||
|
2021
Q4 | $597K | Buy |
|
|||||
|
2021
Q3 | $366K | Buy |
|
|||||
|
2021
Q2 | $550K | Buy |
|
|||||
|
2021
Q1 | $325K | Buy |
|
|||||
|
2020
Q4 | $252K | Buy |
|
|||||
|
2020
Q3 | $182K | Sell |
|
|||||
|
2020
Q2 | $144K | Sell |
|
|||||
|
2020
Q1 | $139K | Sell |
|
|||||
|
2019
Q4 | $191K | Buy |
|
|||||
|
2019
Q3 | $103K | Sell |
|
|||||
|
2019
Q2 | $318K | Buy |
|
|||||
|
2019
Q1 | $305K | Sell |
|
|||||
|
2018
Q4 | $246K | Buy |
|
|||||
|
2018
Q3 | $853K | Buy |
|
|||||
|
2018
Q2 | $553K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $0 | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $4K | Sell |
|
|||||
|
2017
Q1 | $19K | Sell |
|
|||||
|
2016
Q4 | $20K | Sell |
|
|||||
|
2016
Q3 | $44K | Buy |
|
|||||
|
2016
Q2 | $24K | Sell |
|
|||||
|
2016
Q1 | $113K | Buy |
|
|||||
|
2015
Q4 | $39K | Buy |
|
|||||
|
2015
Q3 | $5K | Sell |
|
|||||
|
2015
Q2 | $8K | Buy |
|